Finn Albrechtsen
Direktor/Vorstandsmitglied bei Q-LINEA AB
Aktive Positionen von Finn Albrechtsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Q-LINEA AB | Direktor/Vorstandsmitglied | 13.06.2023 | - |
Karriereverlauf von Finn Albrechtsen
Ehemalige bekannte Positionen von Finn Albrechtsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Statistik
International
| Dänemark | 2 |
| Schweden | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| Q-LINEA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
- Börse
- Insiders
- Finn Albrechtsen
- Erfahrung
